Connect your AI

Opus Genetics IRD Other Income (Expense)

Other Income (Expense) at other companies

MeiraGTx Holdings plcMGTX

-$2.84M-177%

4D Molecular TherapeuticsFDMT

$4.86M-14.0%

Opko HealthOPK

-$9.94M-60.2%

Kodiak Sciences IncKOD

-$22K-320%

Regeneron PharmaceuticalsREGN

$188.3M-39.9%

RegenxbioRGNX

-$6.69M-10.7%

Other financials

Income statement

Revenue$2.2M-50.6%

Operating income-$14.4M-44.7%

Net income-$65.5M-700%

EPS (diluted)-$0.75-213%

Balance sheet

Cash & equivalents$60.0M+43.5%

Total debt$1.2M—

Total equity-$45.8M-1,004%

Total assets$66.8M+38.7%

Cash flow

Operating cash flow-$12.7M-41.5%

Valuation

Market cap$307.14M+442%

Enterprise value$248.38M—

P/S25.6×+21.5×

Profitability

Operating margin-359.1%-68.9pp

Net margin-892.4%-12,322pp

Returns & leverage

Return on equity-449.4%-2,573pp

Debt / equity0.1×—

Current ratio7.1×+5.2×

Where this comes from

Reported directly by Opus Genetics in its filing.

Tagged under the XBRL concept us-gaap:OtherNonoperatingIncomeExpense.

The official record: Opus Genetics’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Opus Genetics's other income (expense).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Opus Genetics's other income (expense)?: Opus Genetics (IRD) reported other income (expense) of $844K in Q1 2026.
How has Opus Genetics's other income (expense) changed year-over-year?: Opus Genetics's other income (expense) increased by 179.5% year-over-year, from $302K to $844K.
What is the long-term trend for Opus Genetics's other income (expense)?: Over 3 years (2021 to 2025), Opus Genetics's other income (expense) has grown at a 133.1% compound annual growth rate (CAGR), from -$157K to $1.99M.
What does other income (expense) mean?: Net total of all non-operating income and expenses not classified in specific line items — a catch-all for miscellaneous financial items.